161 related articles for article (PubMed ID: 35662032)
1. AAPM task group report 303 endorsed by the ABS: MRI implementation in HDR brachytherapy-Considerations from simulation to treatment.
Prisciandaro J; Zoberi JE; Cohen G; Kim Y; Johnson P; Paulson E; Song W; Hwang KP; Erickson B; Beriwal S; Kirisits C; Mourtada F
Med Phys; 2022 Aug; 49(8):e983-e1023. PubMed ID: 35662032
[TBL] [Abstract][Full Text] [Related]
2. GEC-ESTRO/ACROP recommendations for quality assurance of ultrasound imaging in brachytherapy.
Siebert FA; Kirisits C; Hellebust TP; Baltas D; Verhaegen F; Camps S; Pieters B; Kovács G; Thomadsen B
Radiother Oncol; 2020 Jul; 148():51-56. PubMed ID: 32335363
[TBL] [Abstract][Full Text] [Related]
3. Clinical implementation, logistics and workflow guide for MRI image based interstitial HDR brachytherapy for gynecological cancers.
Zhang H; Donnelly ED; Strauss JB; Kang Z; Gopalakrishnan M; Lee PC; Khelashvili G; Nair CK; Lee BH; Sathiaseelan V
J Appl Clin Med Phys; 2019 Nov; 20(11):37-49. PubMed ID: 31600015
[TBL] [Abstract][Full Text] [Related]
4. The effect of catheter displacement and anatomical variations on the dose distribution in MRI-guided focal HDR brachytherapy for prostate cancer.
Maenhout M; van der Voort van Zyp JRN; Borot de Battisti M; Peters M; van Vulpen M; van den Bosch M; Moerland MA
Brachytherapy; 2018; 17(1):68-77. PubMed ID: 28579419
[TBL] [Abstract][Full Text] [Related]
5. Dosimetric impact of contouring and needle reconstruction uncertainties in US-, CT- and MRI-based high-dose-rate prostate brachytherapy treatment planning.
Rylander S; Buus S; Pedersen EM; Bentzen L; Tanderup K
Radiother Oncol; 2017 Apr; 123(1):125-132. PubMed ID: 28284493
[TBL] [Abstract][Full Text] [Related]
6. The influence of a rectal ultrasound probe on the separation between prostate and rectum in high-dose-rate brachytherapy.
Rylander S; Buus S; Bentzen L; Pedersen EM; Tanderup K
Brachytherapy; 2015; 14(5):711-7. PubMed ID: 26164752
[TBL] [Abstract][Full Text] [Related]
7. Magnetic resonance imaging (MRI) markers for MRI-guided high-dose-rate brachytherapy: novel marker-flange for cervical cancer and marker catheters for prostate cancer.
Schindel J; Muruganandham M; Pigge FC; Anderson J; Kim Y
Int J Radiat Oncol Biol Phys; 2013 Jun; 86(2):387-93. PubMed ID: 23433797
[TBL] [Abstract][Full Text] [Related]
8. The American Brachytherapy Society prostate brachytherapy LDR/HDR simulation workshops: Hands-on, step-by-step training in the process of quality assurance.
Frank SJ; Mourtada F; Crook J; Orio PF; Stock RG; Petereit DG; Rossi PJ; Cox BW; Tang C; Kudchadker RJ; Bruno T; Ma J; Sanders J; Keyes M
Brachytherapy; 2020; 19(6):787-793. PubMed ID: 33132070
[TBL] [Abstract][Full Text] [Related]
9. MRI guided focal HDR brachytherapy for localized prostate cancer: Toxicity, biochemical outcome and quality of life.
Maenhout M; Peters M; Moerland MA; Meijer RP; van den Bosch MAAJ; Frank SJ; Nguyen PL; van Vulpen M; van der Voort van Zyp JRN
Radiother Oncol; 2018 Dec; 129(3):554-560. PubMed ID: 30131183
[TBL] [Abstract][Full Text] [Related]
10. Salvage brachytherapy for locally-recurrent prostate cancer after radiation therapy: A comparison of efficacy and toxicity outcomes with high-dose rate and low-dose rate brachytherapy.
Henríquez López I; González-San Segundo C; Vegas JO; Gutierrez C; Hervas A; Cabeza Rodriguez MÁ; Valero Albarrán J; Rodríguez Villalba S; Álvarez Gonzalez A; Sancho Pardo G; Zapatero A; Álvaro PC
Radiother Oncol; 2019 Dec; 141():156-163. PubMed ID: 31570236
[TBL] [Abstract][Full Text] [Related]
11. Automatic multi-catheter detection using deeply supervised convolutional neural network in MRI-guided HDR prostate brachytherapy.
Dai X; Lei Y; Zhang Y; Qiu RLJ; Wang T; Dresser SA; Curran WJ; Patel P; Liu T; Yang X
Med Phys; 2020 Sep; 47(9):4115-4124. PubMed ID: 32484573
[TBL] [Abstract][Full Text] [Related]
12. The relationship between the biochemical control outcomes and the quality of planning of high-dose rate brachytherapy as a boost to external beam radiotherapy for locally and locally advanced prostate cancer using the RTOG-ASTRO Phoenix definition.
Pellizzon AC; Salvajoli J; Novaes P; Maia M; Fogaroli R; Gides D; Horriot R
Int J Med Sci; 2008 Jun; 5(3):113-20. PubMed ID: 18566673
[TBL] [Abstract][Full Text] [Related]
13. Ten-year survival after High-Dose-Rate Brachytherapy combined with External Beam Radiation Therapy in high-risk prostate cancer: A comparison with the Norwegian SPCG-7 cohort.
Wedde TB; Småstuen MC; Brabrand S; Fosså SD; Kaasa S; Tafjord G; Russnes KM; Hellebust TP; Lilleby W
Radiother Oncol; 2019 Mar; 132():211-217. PubMed ID: 30389241
[TBL] [Abstract][Full Text] [Related]
14. Dosimetric feasibility of ablative dose escalated focal monotherapy with MRI-guided high-dose-rate (HDR) brachytherapy for prostate cancer.
Hosni A; Carlone M; Rink A; Ménard C; Chung P; Berlin A
Radiother Oncol; 2017 Jan; 122(1):103-108. PubMed ID: 27916416
[TBL] [Abstract][Full Text] [Related]
15. Pattern of relapse and dose received by the recurrent intraprostatic nodule in low- to intermediate-risk prostate cancer treated with single fraction 19 Gy high-dose-rate brachytherapy.
Mendez LC; Ravi A; Chung H; Tseng CL; Wronski M; Paudel M; McGuffin M; Cheung P; Loblaw A; Morton G
Brachytherapy; 2018; 17(2):291-297. PubMed ID: 29137956
[TBL] [Abstract][Full Text] [Related]
16. Improved prostate delineation in prostate HDR brachytherapy with TRUS-CT deformable registration technology: A pilot study with MRI validation.
Yang X; Rossi PJ; Jani AB; Mao H; Zhou Z; Curran WJ; Liu T
J Appl Clin Med Phys; 2017 Jan; 18(1):202-210. PubMed ID: 28291925
[TBL] [Abstract][Full Text] [Related]
17. High-dose-rate brachytherapy monotherapy versus low-dose-rate brachytherapy with or without external beam radiotherapy for clinically localized prostate cancer.
Yamazaki H; Masui K; Suzuki G; Nakamura S; Yamada K; Okihara K; Shiraishi T; Yoshida K; Kotsuma T; Tanaka E; Otani K; Yoshioka Y; Ogawa K
Radiother Oncol; 2019 Mar; 132():162-170. PubMed ID: 30416045
[TBL] [Abstract][Full Text] [Related]
18. Under-utilisation of high-dose-rate brachytherapy boost in men with intermediate-high risk prostate cancer treated with external beam radiotherapy.
Ong WL; Evans SM; Millar JL
J Med Imaging Radiat Oncol; 2018 Apr; 62(2):256-261. PubMed ID: 29271056
[TBL] [Abstract][Full Text] [Related]
19. Dosimetry of local failure with single dose 19 Gy high-dose-rate brachytherapy for prostate cancer.
Armstrong S; Tsang Y; Lowe G; Tharmalingam H; Alonzi R; Ostler P; Hughes R; Hoskin P
Radiother Oncol; 2021 Apr; 157():93-98. PubMed ID: 33493500
[TBL] [Abstract][Full Text] [Related]
20. Clinical evaluation of an MRI-to-ultrasound deformable image registration algorithm for prostate brachytherapy.
Shaaer A; Davidson M; Semple M; Nicolae A; Mendez LC; Chung H; Loblaw A; Tseng CL; Morton G; Ravi A
Brachytherapy; 2019; 18(1):95-102. PubMed ID: 30287271
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
